Tasly Pharmaceutical Group Co Ltd
SSE:600535

Watchlist Manager
Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Watchlist
Price: 14.46 CNY -1.03%
Market Cap: 21.6B CNY
Have any thoughts about
Tasly Pharmaceutical Group Co Ltd?
Write Note

Tasly Pharmaceutical Group Co Ltd
Investor Relations

In the heart of China's bustling pharmaceutical landscape lies Tasly Pharmaceutical Group Co Ltd, a company intricately blending traditional herbal wisdom with cutting-edge scientific innovation. Founded in 1994, this enterprise has carved a niche in the competitive world of healthcare by focusing on Traditional Chinese Medicine (TCM) while also expanding into chemical medicine and biological drugs. Tasly's ecosystem thrives on the research, development, manufacturing, and marketing of its diverse product portfolio, which includes patent medicines, herbal injections, and health supplements. The crown jewel in its product lineup is the Compound Danshen Dripping Pill, a herbal medicine aimed at cardiovascular ailments, a testament to the company's commitment to merging ancient remedies with modern health solutions. By establishing an extensive distribution network both domestically and internationally, Tasly ensures its unique offerings reach a wide audience, catering not only to China's growing appetite for health products but also tapping into global markets hungry for alternative medicine solutions.

Tasly’s financial engine leverages its broad spectrum of offerings, driven by both consumer demand for TCM and the pharmaceutical industry's appetite for innovation. The company invests significantly in research and development, with a particular emphasis on internationalizing TCM and obtaining global recognition for its products through clinical trials and partnerships. Such strategic actions bolster its competitive edge, positioning Tasly as a leader in an industry where tradition and science converge. Revenue streams are further diversified by the company's health management services and a growing footprint in biotechnology, showcasing its adaptability and forward-thinking approach. This intricate ballet of innovation and tradition enables Tasly Pharmaceutical Group to not just survive but thrive in an industry characterized by rapid advancements and shifting consumer paradigms.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Jing Su
GM & Director
No Bio Available
Ms. Jie Wei
CFO & Head of Accounting
No Bio Available
Mr. Yu Jie
Secretary & VP
No Bio Available
Mr. Jin Yong Cai
Deputy GM & Employee Representative of the Supervisory Board
No Bio Available
Mr. Hongwei Liu
Deputy GM & Vice Chairman of the Supervisory Board
No Bio Available
Mr. Shunnan Zhang
Deputy GM & Supervisor
No Bio Available

Contacts

Address
TIANJIN
Tianjin
(Tasly Modern Traditional Chinese Medicine City), No. 2, Pujihe East Road, Beichen District
Contacts
+862226736999
www.taslypharma.com